Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The report focuses on the Urokinase market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Urokinase market.
Major Players in the Urokinase market are:
Livzon Pharmaceutical Group
NDPHARM
Sandoz
United Biotech
JCR Pharmaceuticals
Taj Pharma
Takeda
Bharat Biotech
Microbix Biosystems Inc
Suzhou No.1 Pharmaceutical
Emcure
PKU High-Tech Huatai Pharmaceutica
Abbott
Novartis
Tianjin Biochem Pharmaceutical
Mylan
Pfizer
Liaoning Weixing Pharmaceutical
Squibb
Mayne Pharma Inc
Zydus Cadila
Teva
On the basis of types, the Urokinase market is primarily split into:
Urokinase Powder
Urokinase Solution
On the basis of applications, the market covers:
Hospital use
Clinic
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Urokinase Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Urokinase Market Overview
1.1 Product Overview and Scope of Urokinase Market
1.2 Urokinase Market Segment by Type
1.2.1 Global Urokinase Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Urokinase Market Segment by Application
1.3.1 Urokinase Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Urokinase Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Urokinase (2017-2029)
1.5.1 Global Urokinase Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Urokinase Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Urokinase Industry
1.7 Impact of Carbon Neutrality on the Urokinase Industry
2 Urokinase Market Upstream and Downstream Analysis
2.1 Urokinase Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Urokinase Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Livzon Pharmaceutical Group
3.1.1 Livzon Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Urokinase Market Performance (2017-2022)
3.1.4 Business Overview
3.2 NDPHARM
3.2.1 NDPHARM Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Urokinase Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Sandoz
3.3.1 Sandoz Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Urokinase Market Performance (2017-2022)
3.3.4 Business Overview
3.4 United Biotech
3.4.1 United Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Urokinase Market Performance (2017-2022)
3.4.4 Business Overview
3.5 JCR Pharmaceuticals
3.5.1 JCR Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Urokinase Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Taj Pharma
3.6.1 Taj Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Urokinase Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Takeda
3.7.1 Takeda Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Urokinase Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Bharat Biotech
3.8.1 Bharat Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Urokinase Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Microbix Biosystems Inc
3.9.1 Microbix Biosystems Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Urokinase Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Suzhou No.1 Pharmaceutical
3.10.1 Suzhou No.1 Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Urokinase Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Emcure
3.11.1 Emcure Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Urokinase Market Performance (2017-2022)
3.11.4 Business Overview
3.12 PKU High-Tech Huatai Pharmaceutica
3.12.1 PKU High-Tech Huatai Pharmaceutica Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Urokinase Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Abbott
3.13.1 Abbott Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Urokinase Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Novartis
3.14.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Urokinase Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Tianjin Biochem Pharmaceutical
3.15.1 Tianjin Biochem Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Urokinase Market Performance (2017-2022)
3.15.4 Business Overview
3.16 Mylan
3.16.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Urokinase Market Performance (2017-2022)
3.16.4 Business Overview
3.17 Pfizer
3.17.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Urokinase Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Liaoning Weixing Pharmaceutical
3.18.1 Liaoning Weixing Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Urokinase Market Performance (2017-2022)
3.18.4 Business Overview
3.19 Squibb
3.19.1 Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 Urokinase Market Performance (2017-2022)
3.19.4 Business Overview
3.20 Mayne Pharma Inc
3.20.1 Mayne Pharma Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Product Profiles, Application and Specification
3.20.3 Urokinase Market Performance (2017-2022)
3.20.4 Business Overview
3.21 Zydus Cadila
3.21.1 Zydus Cadila Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Product Profiles, Application and Specification
3.21.3 Urokinase Market Performance (2017-2022)
3.21.4 Business Overview
3.22 Teva
3.22.1 Teva Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Product Profiles, Application and Specification
3.22.3 Urokinase Market Performance (2017-2022)
3.22.4 Business Overview
4 Global Urokinase Market Landscape by Player
4.1 Global Urokinase Sales and Share by Player (2017-2022)
4.2 Global Urokinase Revenue and Market Share by Player (2017-2022)
4.3 Global Urokinase Average Price by Player (2017-2022)
4.4 Global Urokinase Gross Margin by Player (2017-2022)
4.5 Urokinase Market Competitive Situation and Trends
4.5.1 Urokinase Market Concentration Rate
4.5.2 Urokinase Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Urokinase Sales, Revenue, Price Trend by Type
5.1 Global Urokinase Sales and Market Share by Type (2017-2022)
5.2 Global Urokinase Revenue and Market Share by Type (2017-2022)
5.3 Global Urokinase Price by Type (2017-2022)
5.4 Global Urokinase Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Urokinase Sales, Revenue and Growth Rate of Urokinase Powder (2017-2022)
5.4.2 Global Urokinase Sales, Revenue and Growth Rate of Urokinase Solution (2017-2022)
6 Global Urokinase Market Analysis by Application
6.1 Global Urokinase Consumption and Market Share by Application (2017-2022)
6.2 Global Urokinase Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Urokinase Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Urokinase Consumption and Growth Rate of Hospital use (2017-2022)
6.3.2 Global Urokinase Consumption and Growth Rate of Clinic (2017-2022)
6.3.3 Global Urokinase Consumption and Growth Rate of Others (2017-2022)
7 Global Urokinase Sales and Revenue Region Wise (2017-2022)
7.1 Global Urokinase Sales and Market Share, Region Wise (2017-2022)
7.2 Global Urokinase Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Urokinase Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Urokinase Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Urokinase Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Urokinase Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Urokinase Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Urokinase Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Urokinase Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Urokinase Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Urokinase Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Urokinase Market Forecast (2022-2029)
8.1 Global Urokinase Sales, Revenue Forecast (2022-2029)
8.1.1 Global Urokinase Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Urokinase Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Urokinase Price and Trend Forecast (2022-2029)
8.2 Global Urokinase Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Urokinase Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Urokinase Sales and Revenue Forecast (2022-2029)
8.2.3 China Urokinase Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Urokinase Sales and Revenue Forecast (2022-2029)
8.2.5 India Urokinase Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Urokinase Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Urokinase Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Urokinase Sales and Revenue Forecast (2022-2029)
8.3 Global Urokinase Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Urokinase Revenue and Growth Rate of Urokinase Powder (2022-2029)
8.3.2 Global Urokinase Revenue and Growth Rate of Urokinase Solution (2022-2029)
8.4 Global Urokinase Consumption Forecast by Application (2022-2029)
8.4.1 Global Urokinase Consumption Value and Growth Rate of Hospital use (2022-2029)
8.4.2 Global Urokinase Consumption Value and Growth Rate of Clinic (2022-2029)
8.4.3 Global Urokinase Consumption Value and Growth Rate of Others (2022-2029)
8.5 Urokinase Market Forecast Under COVID-19
9 Industry Outlook
9.1 Urokinase Market Drivers Analysis
9.2 Urokinase Market Restraints and Challenges
9.3 Urokinase Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Urokinase Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Urokinase Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Urokinase Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
